Model of tumor dormancy/recurrence after short-term chemotherapy.
Although many tumors regress in response to neoadjuvant chemotherapy, residual tumor cells are detected in most cancer patients post-treatment. These residual tumor cells are thought to remain dormant for years before resuming growth, resulting in tumor recurrence. Considering that recurrent tumors...
Saved in:
| Main Authors: | Shenduo Li, Margaret Kennedy, Sturgis Payne, Kelly Kennedy, Victoria L Seewaldt, Salvatore V Pizzo, Robin E Bachelder |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0098021&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial Note: Model of tumor dormancy/recurrence after short-term chemotherapy.
by: PLOS One Editors
Published: (2025-01-01) -
Tumor dormancy and relapse: understanding the molecular mechanisms of cancer recurrence
by: Muhammad Tufail, et al.
Published: (2025-02-01) -
Proton beam therapy in repeat irradiation of recurrent head and neck tumors: analysis of short-term results
by: D. I. Smyk, et al.
Published: (2023-03-01) -
Verification of non-deep physiological dormancy and treatment to overcome seed dormancy in Campomanesia phaea (O. Berg) Landrum
by: Mariane Jeronimo Forte Sinhorini, et al.
Published: (2025-05-01) -
Short-term outcomes of preoperative chemotherapy in patients with upper ampullary rectal cancer
by: A. Yu. Dobrodeev, et al.
Published: (2022-01-01)